Literature DB >> 23627692

The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation.

H G Otten1, M C Verhaar, H P E Borst, M van Eck, W G J van Ginkel, R J Hené, A D van Zuilen.   

Abstract

Antibodies recognizing denatured human leucocyte antigen (HLA) can co-react with epitopes on intact HLA or recognize cryptic epitopes which are normally unaccessible to HLA antibodies. Their specificity cannot be distinguished by single antigen beads (SAB) alone, as they carry a mixture of intact and denatured HLA. In this study, we selected pretransplant sera containing donor-specific HLA class I antibodies (DSA) according to regular SAB analysis from 156 kidney transplant recipients. These sera were analysed using a SAB preparation (iBeads) which is largely devoid of denatured HLA class I, and SAB coated with denatured HLA class I antigens. A total of 241 class I DSA were found by regular SAB analysis, of which 152 (63%) were also found by iBeads, whereas 28 (11%) were caused by reactivity with denatured DNA. Patients with DSA defined either by regular SAB or iBeads showed a significantly lower graft survival rate (P = 0·007) compared to those without HLA class I DSA, whereas reactivity to exclusively denatured HLA was not associated with decreased graft survival. In addition, DSA defined by reactivity to class I SAB or class I iBeads occurred more frequently in female patients and in patients with historic HLA sensitization, whereas reactivity to denatured HLA class I was not associated with any of these parameters. Our data suggest that pretransplant donor-specific antibodies against denatured HLA are clinically irrelevant in patients already sensitized against intact HLA.
© 2013 British Society for Immunology.

Entities:  

Keywords:  denatured HLA; donor specific antibodies; kidney transplantation; single-antigen bead array

Mesh:

Substances:

Year:  2013        PMID: 23627692      PMCID: PMC3949641          DOI: 10.1111/cei.12127

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner.

Authors:  Yi-Ping Jin; Ram Pyare Singh; Ze-Ying Du; Ayyappan K Rajasekaran; Enrique Rozengurt; Elaine F Reed
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

2.  HLA antibody identification with single antigen beads compared to conventional methods.

Authors:  N El-Awar; J Lee; P I Terasaki
Journal:  Hum Immunol       Date:  2005-10-07       Impact factor: 2.850

3.  The "in situ" expression of human leukocyte antigen class I antigens is not altered by cryopreservation in human arterial allografts.

Authors:  G Pasquinelli; M P Pistillo; F Ricci; M Buzzi; P L Tazzari; L Foroni; C Manferdini; C Ceccarelli; A Stella; R Conte
Journal:  Cell Tissue Bank       Date:  2006-10-25       Impact factor: 1.522

4.  Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

Authors:  Brian D Tait; Caner Süsal; Howard M Gebel; Peter W Nickerson; Andrea A Zachary; Frans H J Claas; Elaine F Reed; Robert A Bray; Patricia Campbell; Jeremy R Chapman; P Toby Coates; Robert B Colvin; Emanuele Cozzi; Ilias I N Doxiadis; Susan V Fuggle; John Gill; Denis Glotz; Nils Lachmann; Thalachallour Mohanakumar; Nicole Suciu-Foca; Suchitra Sumitran-Holgersson; Kazunari Tanabe; Craig J Taylor; Dolly B Tyan; Angela Webster; Adriana Zeevi; Gerhard Opelz
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

5.  Pretransplant risk assessment in renal allograft recipients using virtual crossmatching.

Authors:  D Bielmann; G Hönger; D Lutz; M J Mihatsch; J Steiger; S Schaub
Journal:  Am J Transplant       Date:  2007-03       Impact factor: 8.086

6.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

7.  "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males.

Authors:  Luis E Morales-Buenrostro; Paul I Terasaki; Lluvia A Marino-Vázquez; Jar-How Lee; Nadim El-Awar; Josefina Alberú
Journal:  Transplantation       Date:  2008-10-27       Impact factor: 4.939

8.  Clustering of class I HLA molecules on the surfaces of activated and transformed human cells.

Authors:  J Matko; Y Bushkin; T Wei; M Edidin
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

9.  Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.

Authors:  Federico Perosa; Grazia Luccarelli; Marcella Prete; Elvira Favoino; Soldano Ferrone; Franco Dammacco
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

10.  Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients.

Authors:  G E Rodey; J F Neylan; J D Whelchel; K W Revels; R A Bray
Journal:  Hum Immunol       Date:  1994-04       Impact factor: 2.850

View more
  20 in total

Review 1.  Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.

Authors:  Gerald Schlaf; Beatrix Pollok-Kopp; Wolfgang W Altermann
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

2.  Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions.

Authors:  Vadim Jucaud; Mepur H Ravindranath; Paul I Terasaki
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

3.  Conformational Variants of HLA-I Antigens on Luminex Single Antigen Beads.

Authors:  Jonathan Visentin; Gwendaline Guidicelli; Jean-Luc Taupin
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

4.  The utility of second single antigen bead assay: Clearing the water or stirring up mud?

Authors:  Harold C Sullivan; Scott M Krummey; Howard M Gebel; Robert A Bray
Journal:  Hum Immunol       Date:  2020-10-06       Impact factor: 2.850

5.  Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing.

Authors:  Christina L Dean; Scott M Krummey; Howard M Gebel; Robert A Bray; Harold C Sullivan
Journal:  Hum Immunol       Date:  2020-01-06       Impact factor: 2.850

6.  Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform.

Authors:  Mepur H Ravindranath; Edward J Filippone; Grace Mahowald; Carly Callender; Adarsh Babu; Susan Saidman; Soldano Ferrone
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

Review 7.  Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians.

Authors:  Carrie A Schinstock; Manish J Gandhi; Mark D Stegall
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

Review 8.  Human leukocyte antigens and alloimmunization in heart transplantation: an open debate.

Authors:  Antonietta Picascia; Vincenzo Grimaldi; Amelia Casamassimi; Maria Rosaria De Pascale; Concetta Schiano; Claudio Napoli
Journal:  J Cardiovasc Transl Res       Date:  2014-09-05       Impact factor: 4.132

9.  Monitoring native HLA-I trimer specific antibodies in Luminex multiplex single antigen bead assay: Evaluation of beadsets from different manufacturers.

Authors:  Mepur H Ravindranath; Vadim Jucaud; Soldano Ferrone
Journal:  J Immunol Methods       Date:  2017-08-04       Impact factor: 2.303

Review 10.  Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen.

Authors:  Michelle J Hickey; Nicole M Valenzuela; Elaine F Reed
Journal:  Front Immunol       Date:  2016-02-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.